[PLX] YoY Quarter Result on 31-Dec-2015 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- 2,008.38%
YoY- 960.79%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 27,018 2,469 2,081 -11,195 1,384 1,122 48 187.20%
PBT 9,781 -15,141 -2,624 -12,419 -8,469 -10,885 968 47.00%
Tax 99 916 -189 -85,260 57 0 -1,741 -
NP 9,781 -15,141 -2,624 72,900 -8,469 -10,885 -9,877 -
Tax Rate -1.01% - - - - - 179.86% -
Total Cost 17,237 17,610 4,705 -84,095 9,853 12,007 9,925 9.63%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 36.20 -613.24 -126.09 -651.18 -611.92 -970.14 -20,577.08 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS 0.66 -1.08 -0.21 7.31 -0.91 -1.18 -1.07 -
EPS Diluted 0.66 -1.04 -0.21 7.31 -0.91 -1.17 -1.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.